Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.


Cardiac Toxicity in Nonmetastatic CRPC

July 31st 2019

Management of Adverse Events in M0 CRPC

July 31st 2019

Practical Advice on Follow-Up for Patients with M0 CRPC

July 31st 2019

Benefits of Newly Approved Drugs for M0 CRPC

July 31st 2019

MFS as a Clinical Endpoint in nmCRPC

July 31st 2019

Imaging Utilized in Diagnosis of CRPC

July 31st 2019

Advancements in Nonmetastatic CRPC

July 31st 2019

TRK Inhibition: Future Challenges and Evolutions

July 30th 2019

Use of TRK Inhibition in Specific Tumor Types

July 30th 2019

The Importance and Evolution of NGS Testing

July 30th 2019

Envisioning Use of TRK Inhibitors in Clinical Practice

July 30th 2019

Other Approaches to TRK-Fusion Cancers

July 30th 2019

TRK Inhibition in CNS Tumors or Metastases

July 30th 2019

Treating Pediatric Patients With TRK Inhibitors

July 30th 2019

Considering Available Data for Entrectinib

July 30th 2019

TRK Inhibition: Personal Experience With Larotrectinib

July 30th 2019

Larotrectinib for NTRK Fusions: Patient Selection

July 30th 2019

Updated Data for Larotrectinib

July 30th 2019

Larotrectinib: The First FDA-Approved TRK Inhibitor

July 30th 2019

NTRK: An Attractive Target for Therapy

July 30th 2019